ABOUT THE STUDY
Why do we want to do this research?
In the UK people of African or Caribbean descent are at increased risk of developing Type 2 Diabetes. Programmes involving healthy eating and physical activity are important to help people manage their illness, however they need to be responsive to an individual’s lifestyle and culture to be most effective. This research is being carried to develop a programme of healthy eating and lifestyle advice for diabetes care, in African and Caribbean communities. We are going to talk to members of these communities who have diabetes, health professionals who support them and community and religious leaders. We would like to understand the factors that influence lifestyle behaviour and how advice can be tailored to meet health needs while taking into account the cultural factors that influence health choices.
What is the aim of this research?
This research is to develop and evaluate a culturally-tailored healthy eating and active lifestyle programme for Type 2 Diabetes, specifically for the African and Caribbean community.
Working in partnership with the African & Caribbean community,
We are designing the HEAL-D programme in partnership with African and Caribbean Type 2 Diabetes patients, their Healthcare providers and Community and Church Leaders. We will work with patients to understand their experience of managing their diet and lifestyle to support their health and to design an programme of advice and education that is tailored to the preferences and habits of African and Caribbean communities.
The initial phases of the study, to design the programme, are being carried out in partnership with African and Caribbean Type 2 Diabetes patients, the Heathcare Professionals that support them and Community and Faith Leaders. We will meet patients in groups, and interview Community Leaders and Healthcare professionals to help us understand how best to structure and deliver the programme. We will then work with all three groups in workshops to agree the programme.
The next phase will evaluate this programme in a feasibility study with patients from African and Caribbean Communities.